Feto-maternal alloimmune thrombocytopenia: A literature review and statistical analysis

Australian and New Zealand Journal of Obstetrics and Gynaecology

Volumn 41, Issue 1, 2001, Pages 45-55

  Spencer, Jillian A ^a   Burrows, Robert F ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN; THROMBOCYTE ANTIGEN;

ADOLESCENT; ADULT; ALLOIMMUNITY; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MOTHER FETUS RELATIONSHIP; NEUROLOGIC DISEASE; NEWBORN; NEWBORN MORTALITY; PRENATAL CARE; PRIORITY JOURNAL; REVIEW; RISK; STATISTICAL ANALYSIS; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; TREATMENT OUTCOME;

ANTIGENS, HUMAN PLATELET; FEMALE; FETAL DISEASES; FETOMATERNAL TRANSFUSION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; MORBIDITY; PLATELET COUNT; PLATELET TRANSFUSION; PREGNANCY; PREGNANCY OUTCOME; RISK FACTORS; THROMBOCYTOPENIA; TREATMENT OUTCOME;

EID: 0035095881     PISSN: 00048666     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1479-828X.2001.tb01293.x     Document Type: Article

References (164)

1. Alloimmunization to the PlA1 platelet antigen: Results of a prospective study
2. Fetal and neonatal alloimmune thrombocytopenia: Current trends in diagnosis and therapy
3. Neonatal alloimmune thrombocytopenia
4. Determination of platelet antigens and glycoproteins in the human fetus
5. Neonatal alloimmune thrombocytopenia: Current considerations
6. Elevated platelet-associated IgG in PlA1-negative mothers following sensitization to the PlA1 antigen during pregnancy
7. Management of fetal and neonatal alloimmune thrombocytopenia
8. Platelet vulnerability in the fetus/neonate with neonatal alloimmune thrombocytopenia
9. Antenatal management of the thrombocytopenias
10. Neonatal thrombocytopenia: Incidence, serological and clinical observations
11. Fetal thrombocytopenia and its relation to maternal thrombocytopenia
12. Baka, a new platelet-specific antigen involved in neonatal allo-immune thrombocytopenia
13. A new platelet antigen system, Yuka/Yukb
14. A new platelet-specific alloantigen Bra. Report of 4 cases with neonatal alloimmune thrombocytopenia
15. Intracranial hemorrhage in utero as a complication of isoimmune thrombocytopenia
16. Therapy with intravenous immunoglobulin G (ivIgG) during pregnancy for fetal alloimmune (HPA-1a(Zwa)) thrombocytopenic purpura
17. Platelet anti-Bakb antibody associated with neonatal alloimmune thrombocytopenia
18. Devastating sequelae of alloimmune thrombocytopenia: An entity that deserves more attention
19. Association of isoimmune thrombocytopenia and neonatal hyperinsulinism/hypoglycemia
20. Use of "compatible" platelet transfusions in treatment of congenital isoimmune thrombocytopenic purpura
21. Pemphigoid gestationis and neonatal alloimmune thrombocytopenia
22. Neonatal alloimmune thrombocytopenia due to anti-HPA-5b (Br(a), Zav(a), Hca): The importance of third-generation platelet antibody detection techniques, a case report
23. Intravenous gammaglobulin therapy for neonatal alloimmune thrombocytopenia
24. Neonatal alloimmune amegakaryocytosis: Case report
25. Alloimmunization to the PLA1 platelet antigen: Results of a prospective study
26. Alloimmune thrombocytopenia. Review from a neonatal intensive care unit
27. Alloimmune thrombocytopenia of the newborn: Neurodevelopmental sequelae
28. Maternal immunization to Gov system alloantigens on human platelets
29. Neonatal alloimmune thrombocytopenia. Case reports, diagnostic and therapeutic considerations
30. Neonatal alloimmune thrombocytopenia: Spontaneous in utero intracranial hemorrhage
31. Alloimmune neonatal thrombocytopenia associated with incidental maternal thrombocytopenia
32. Antenatal treatment of neonatal alloimmune thrombocytopenia
33. Antenatal management of fetal alloimmune and autoimmune thrombocytopenia
34. Antenatal treatment of fetal alloimmune cytopenias
35. Neonatal alloimmune thrombocytopenia due to HLA-A2 antibody
36. Two cases of neo-natal thrombocytopenia due to maternal iso-immunization against leuco-platelet antigens
37. Prenatal treatment of alloimmune thrombocytopenia
38. Monitoring anti-HPA-1a platelet antibody levels during pregnancy using the MAIPA test
39. Recurrent intracranial haemorrhages in utero in an infant with alloimmune thrombocytopenia. Case report
40. Cerebral hemorrhage in alloimmune thrombocytopenia
41. Neonatal alloimmune thrombocytopenic purpura: A case report
42. Alloimmune neonatal thrombocytopenia: Platelet antibody detection using the indirect immunofluorescence test (IIFT)
43. The prenatal identification of fetal compatibility in neonatal alloimmune thrombocytopenia using amniotic fluid and variable number of tandem repeat (VNTR) analysis
44. Intravenous immunoglobulin for neonatal isoimmune thrombocytopenia
45. Antenatal diagnosis and management of fetomaternal alloimmmune thrombocytopenia
46. Antenatal screening for fetal alloimmune thrombocytopenia: The results of a pilot study
47. Frequency of immune thrombocytopenia in newborns: A prospective study. Immune Thrombocytopenia Working Group
48. Neonatal alloimmune thrombocytopenia caused by an antibody to the Bak(a) antigen
49. Optic atrophy as a complication of neonatal alloimmune thrombocytopenia
50. Neonatal alloimmune thrombocytopenic purpura and congenital porencephaly in two siblings associated with a "new" maternal antiplatelet antibody
51. Isoimmune neonatal thrombocytopenic purpura
52. Therapy with intravenous immunoglobulin G (ivIgG) during pregnancy for fetal alloimmune (HPA-1a(Zwa)) thrombocytopenic purpura
53. Very early intracranial haemorrhage in alloimmune fetal thrombocytopenia
54. Neonatal alloimmune thrombocytopenia: Current considerations
55. Significance of platelet antibodies in neonatal thrombocytopenic purpura affecting a pair of siblings
56. Neonatal allo-immune thrombocytopenia. A case report and review of obstetric management
57. Immunologic mechanisms in idiopathic and neonatal thrombocytopenic purpura
58. In utero cerebral hemorrhage in alloimmune thrombocytopenia
59. Neonatal alloimmune thrombocytopenic purpura induced by anti-Bak(a): A case report and review of the literature
60. Intracranial hemorrhage in utero re thrombocytopenia
61. Clinical and serological findings in alloimmune neonatal thrombocytopenia
62. Platelet washing with a blood cell processor
63. Antenatal care in pregnancies at risk of alloimmune thrombocytopenia: Report of 19 cases in 16 families
64. Management of alloimmune thrombocytopenia: Antenatal diagnosis and in utero transfusion of maternal platelets
65. HPA-5b (Br(a)) neonatal alloimmune thrombocytopenia: Clinical and immunological analysis of 39 cases
66. Neonatal isoimmune thrombocytopenia. The natural course and management and detection of maternal antibody
67. Alloimmune thrombocytopenia may be associated with systemic disease
68. A new platelet alloantigen, Tua, on glycoprotein IIIa associated with neonatal alloimmune thrombocytopenia in two families
69. A new low-frequency platelet alloantigen, Vaa, on glycoprotein llb llla associated with neonatal alloimmune thrombocytopenia
70. Neonatal thrombocytopenia due to passive immunization: Prenatal diagnosis and distinction between maternal platelet alloantibodies and autoantibodies
71. Molecular genotyping of fetal platelet antigens with uncultured amniocytes
72. A new platelet-specific alloantigen Bra. Report of 4 cases with neonatal alloimmune thrombocytopenia
73. Neonatal alloimmune thrombocytopenia due to anti-Brb (HPA-5a). Report of three cases in two families
74. Alloimmunization against Iy, a low-frequency antigen on platelet glycoprotein Ib/IX as a cause of severe neonatal alloimmune thrombocytopenic purpura
75. Antenatal invasive and noninvasive management of alloimmune thrombocytopenia
76. Maternal intravenous immunoglobulin treatment does not prevent intracranial haemorrhage in fetal alloimmune thrombocytopenia
77. Sra, a private platelet antigen on glycoprotein IIIa associated with neonatal alloimmune thrombocytopenia
78. Single point mutation in human glycoprotein IIIa is associated with a new platelet-specific alloantigen (Mo) involved in neonatal alloimmune thrombocytopenia
79. A case of severe neonatal thrombocytopenia with schizencephaly associated with anti-HPA-1b and anti-HPA-2a
80. Ultrasound in congenital intracranial haemorrhage secondary to isoimmune thrombocytopenia
81. Neonatal immune neutropenia following the administration of intravenous immune globulin
82. Neonatal alloimmune thrombocytopenia. A case report and review of the literature
83. Neonatal alloimmune thrombocytopenia in Taiwan due to an antibody against a labile component of HPA-3a (Baka)
84. Neonatal alloimmune thrombocytopenia due to anti-PLA1 (anti-HPA-1a): Importance of paternal and fetal platelet typing for assessment of fetal risk
85. The in utero diagnosis and management of alloimmune thrombocytopenia
86. Antenatal treatment of alloimmune thrombocytopenia
87. Neonatal graft versus host disease following transfusion of maternal platelets
88. Difficulties in the antenatal assessment of neonatal alloimmune thrombocytopenia
89. High-dose immunoglobulin in the antenatal treatment of neonatal alloimmune thrombocytopenia: Case report and review
90. Antenatal fetal therapy for neonatal allo-immune thrombocytopenia with high dose immunoglobulin
91. Clinical significance of platelet alloantibodies detected in immunofluorescence test (neonatal alloimmune thrombocytopenia and post-transfusion purpura)
92. Intravenous immunoglobulin in treatment of neonatal isoimmune thrombocytopenia
93. Neonatal alloimmune thrombocytopenic purpura associated with sensitization against the platelet-specific antigen Yuka
94. Perinatal intracranial hemorrhage due to severe neonatal alloimmune thrombocytopenic purpura. (AITP) associated with anti-Yukb (HPA-4a) antibodies
95. Prenatal diagnosis of neonatal alloimmune thrombocytopenia using allele-specific oligonucleotide probes
96. Neonatal alloimmune thrombocytopenia due to a new platelet-specific alloantibody
97. Isoimmune neonatal thrombocytopenia in twin infants
98. Neonatal isoimmune purpura: Response to platelet infusions
99. Obstetric management of isoimmune thrombocytopenia
100. Neonatal thrombocytopenia in HLA-DR, -DQ, -DP-typed mother due to rare anti-HPA-1b (PLA2) (Zwb) fetomaternal immunization
101. Prolonged neonatal alloimmune thrombocytopenic purpura associated with anti-bak(a). Two cases in siblings
102. Failure of antenatal high-dose immunoglobulin to improve fetal platelet count in Neonatal allo-immune thrombocytopenia
103. Detection of alloimmune thrombocytopenia as cause of isolated hydrocephalus by fetal blood sampling
104. Intracranial hemorrhage in utero due to isoimmune neonatal thrombocytopenia
105. Anti-HPA-4b (anti-Yuk(a)) neonatal alloimmune thrombocytopenia: First report in a Causasian family
106. Neonatal alloimmune thrombocytopenia due to fetomaternal Zwb incompatibility
107. Prenatal treatment of fetal alloimmune thrombocytopenia
108. High-dose IgG treatment for neonatal alloimmune thrombocytopenia
109. Antenatal management of severe feto-maternal alloimmune thrombocytopenia: HLA incompatibility may affect responses to fetal platelet transfusions
110. Antenatal management of fetomaternal alloimmune thrombocytopenia - Report of 15 affected pregnancies
111. CS lesions in neonatal isoimmune thrombocytopenia
112. Anti-Bak(a) neonatal alloimmune thrombocytopenia: Possible prevention by intravenous immunoglobulin
113. In-utero platelet transfusion for alloimmune thrombocytopenia
114. Continuing controversy in alloimmune thrombocytopenia: Fetal hyperimmunoglobulinemia fails to prevent thrombocytopenia
115. Max(a), a new low-frequency platelet-specific antigen localized on glycoprotein IIb, is associated with neonatal alloimmune thrombocytopenia
116. Thrombocytopenia in 4 newborn siblings
117. Pedigree of the major histocompatibility complex in a family with a neonatal alloimmune thrombocytopenia
118. Neonatal alloimmune thrombocytopenia after maternal immunization with paternal mononuclear cells: Successful treatment with intravenous gamma globulin
119. Isoimmune neonatal thrombocytopenic purpura: Clinical and therapeutic considerations
120. HPA-10W(b) (La(a)): Genetic determination of a new platelet-specific alloantigen on glycoprotein IIIa and its expression in COS-7 cells
121. High-dose intravenous gammaglobulin for neonatal alloimmune thrombocytopenia in twins
122. Isoimmune neonatal purpura. Case report and review
123. Alloimmune thrombocytopenia: In utero treatment by high doses of intravenous gamma globulins
124. A second case of neonatal alloimmune thrombocytopenia by anti-HPA-4b (anti-Yuka) in a Caucasian family
125. Breast feeding in neonatal alloimmune thrombocytopenia
126. Radiological case of the month: Neonatal alloimmune thrombocytopenia
127. Successful treatment of fetal cardiac arrest by left ventricular exchange transfusion
128. Feto-maternal alloimmune thrombocytopenia associated with anti-HPA-5a - The first Australian case
129. Congenital thrombocytopenic purpura: Observation on three infants born of a non-affected mother: Demonstration of platelet agglutinins and evidence for platelet isoimmunization
130. Neonatal alloimmune, thrombocytopenia in consecutive pregnancies
131. Yuka, a new platelet antigen involved in two cases of neonatal alloimmune thrombocytopenia
132. A new platelet antigen system, Yuka/Yukb
133. High-dose intravenous immunoglobulin in the prenatal management of neonatal alloimmune thrombocytopenia
134. Failure of cesarean section to prevent intracranial hemorrhage in siblings with isoimmune neonatal thrombocytopenia
135. The treatment of neonatal isoimmune thrombocytopenia with intravenous immunoglobulin (IgG i.v.)
136. Human platelet antigen-1 (Zw) typing of fetuses by analysis of polymerase chain reaction-amplified genomic DNA from amniocytes
137. A new private platelet antigen, Groa, localised on glycoprotein IIIa, involved in neonatal alloimmune thrombocytopenia
138. Management of isoimmune neonatal thrombocytopenia
139. Severe alloimmune neonatal thrombocytopenia due to specific HLA antibodies
140. High-dose intravenous gammaglobulin (IVG) in neonatal immune thrombocytopenia
141. Neonatal alloimmune thrombocytopenia involving HPA-5b (Br(a)): A rare Japanese case
142. Isoimmune thrombocytopenia: Coordinated management of mother and infant
143. Iso-Immune neonatal purpura caused by Anti-PlGrLy B1
144. The frequency of platelet alloantibodies in pregnant women and the occurrence and management of neonatal alloimmune thrombocytopenic purpura
145. Neonatal alloimmune thrombocytopenia associated with anti-human platelet antigen-3a antibody
146. Neonatal thrombocytopenia and hidden maternal autoimmunity
147. Treatment of isoimmune thrombocytopenia of the newborn with transfusion of maternal platelets
148. Neonatal alloimmune thrombocytopenia complicated by maternal autoimmune thrombocytopenia
149. Baka, a new platelet-specific antigen involved in neonatal allo-immune thrombocytopenia
150. In vitro culture of colony forming unit-megakaryocyte (CFU-MK) in fetal alloimmune thrombocytopenia
151. Fetal platelet transfusion in the management of alloimmune thrombocytopenia
152. Direct fetal administration of immunoglobulins: Another disappointing therapy in alloimmune thrombocytopenia
153. Antenatal treatment of fetal alloimmune thrombocytopenia
154. Provision of random-donor platelets (HPA-1a positive) in neonatal alloimmune thrombocytopenia due to anti HPA-1a alloantibodies
155. Intracranial hemorrhage in utero as a complication of isoimmune thrombocytopenia
156. In-utero fetal therapy with immunoglobulin for alloimmune thrombocytopenia
157. Alloimmune thrombocytopenia: Fetal and neonatal losses related to cordocentesis
158. Idiopathic thrombocytopenic purpura in pregnancy treated with pulsed high-dose oral dexamethasone
159. Neonatal alloimmune thrombocytopenic purpura
160. Antenatal management of alloimmune thrombocytopenia with intravenous gama-globulin: A randomized trial of the addition of low-dose steroid to intravenous gama-globulin
161. Neonatal alloimmune thrombocytopenia (nAIT): A prospective case accumulation study
162. Fetal alloimmune thrombocytopenia
163. 348 cases of suspected neonatal alloimmune thrombocytopenia
164. Feto-maternal alloimmune thrombocytopenia: Antenatal therapy with IvIgG and steroids - More questions than answers